EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood …

2025年1月30日 · Eprex 10000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

Actual Medicinal Product (AMP) - Eprex 2,000units/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd)

Actual Medicinal Product pack (AMPP) - Eprex 30,000units/0.75ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection

2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

EPREX is prescribed to stimulate your bone marrow to produce more red blood cells. EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant …

2017年7月13日 · Treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have …

Erythropoietin is used to treat anaemia caused by cancer or cancer treatments. Find out when it is given and possible side effects of Erythropoietin.

Evidence-based recommendations on erythropoiesis-stimulating agents (epoetin alfa [Eprex], epoetin beta [NeoRecormon], epoetin theta, epoeitin zeta [Retacrit] and darbepoetin alfa …

Actual Medicinal Product (AMP) - Eprex 30,000units/0.75ml solution for injection pre-filled syringes (Janssen-Cilag Ltd)